• Physician Lead, Tuberculosis Service, West Park Healthcare Centre
• Member, Provincial Infectious Diseases Advisory Committee – Communicable Disease (PIDAC-CD) Tuberculosis Working Group, Public Health Ontario
• Member, Provincial Infectious Diseases Advisory Committee – Communicable Disease (PIDAC-CD) Nontuberculous Mycobacteria Working Group, Public Health Ontario
• Member, Canadian Tuberculosis Elimination Network
Areas of Expertise
• Tuberculosis (TB)
• Nontuberculous mycobacteria (NTM)
• Respiratory Medicine
• Masters of Public Health, Clinical Effectiveness, Harvard University, Boston
• Doctor of Medicine, University of Toronto
• Bachelor of Science, University of Windsor
• Assistant Professor, Department of Medicine, University of Toronto
• Staff Respirologist, University Health Network (UHN)
• Staff Respirologist, Nontuberculous mycobacteria program, Toronto Western Hospital, UHN
Doctors Notes-Why Tuberculosis remains a problem in Canada - The Toronto Star
Sample of Publications
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-
Austin A, Bombardier C, and Marras TK. Increased risk of mycobacterial infections
associated with anti-rheumatic medications. Thorax Published Online First: [24 April 2015] doi:10.1136/thoraxjnl-2014- 206470.
Brode SK, Varadi R, McNamee J, Malek N, Stewart S, and Avendano M. Multidrug resistant tuberculosis: Treatment and Outcomes of 93 Patients. Canadian Respiratory Journal. 2014 Dec 10. pii: 16560.
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, and Marras TK. (2014). Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 146(3): 563-572.